Idiopathic Pulmonary Hemosiderosis Overview

Save information for later
Sign Up

Learn About Idiopathic Pulmonary Hemosiderosis

What is the definition of Idiopathic Pulmonary Hemosiderosis?
Idiopathic pulmonary hemosiderosis is a rare disease characterized by repeated episodes of bleeding into the lungs, which can cause anemia and lung disease. The body is able to remove most of the blood from the lungs, but a large amount of iron is left behind. Over time, this iron can cause permanent damage to the lungs (fibrosis). Symptoms can resemble pneumonia and include coughing, coughing up blood (hemoptysis), difficulty breathing, and wheezing. The cause of Idiopathic pulmonary hemosiderosis is unknown. Diagnosis is based on ruling out other kinds of pulmonary hemosiderosis, and tests may include imaging, laboratory tests, and a lung biopsy.
What are the alternative names for Idiopathic Pulmonary Hemosiderosis?
  • Idiopathic pulmonary hemosiderosis
  • Siderosis
  • Alveolar hypoventilation syndrome
  • Hemosiderosis, pulmonary, with deficiency of gamma-a globulin
  • Pulmonary hemosiderosis
Who are the top Idiopathic Pulmonary Hemosiderosis Local Doctors?
Demet G. Yasar
Advanced in Idiopathic Pulmonary Hemosiderosis
Dr. Demet G. Yasar
Hematology
Advanced in Idiopathic Pulmonary Hemosiderosis
Dr. Demet G. Yasar
Hematology

Vince Lombardi Cancer Clinic

2845 Greenbrier Rd, Ste 250, 
Green Bay, WI 
920-288-4180
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Demet Yasar is a Hematologist in Green Bay, Wisconsin. Dr. Yasar is rated as an Advanced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. Her top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Myelodysplastic Syndrome (MDS).

Advanced in Idiopathic Pulmonary Hemosiderosis
Dr. Christina A. Saurel
Hematology Oncology | Oncology | Hematology
Advanced in Idiopathic Pulmonary Hemosiderosis
Dr. Christina A. Saurel
Hematology Oncology | Oncology | Hematology

Physiotherapy Associates Inc

3605 Braselton Hwy, Suite 101, 
Dacula, GA 
770-904-0772
Languages Spoken:
English, French
See accepted insurances
Accepting New Patients
Offers Telehealth

Christina Saurel is a Hematologist Oncology specialist and an Oncologist in Dacula, Georgia. Dr. Saurel is rated as an Advanced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. Her top areas of expertise are Multiple Carboxylase Deficiency, Vitamin B12 Deficiency Anemia, Folate Deficiency, and Subacute Combined Degeneration. Dr. Saurel is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Idiopathic Pulmonary Hemosiderosis
Dr. David Z. Drew
Hematology Oncology | Hematology | Oncology
Advanced in Idiopathic Pulmonary Hemosiderosis
Dr. David Z. Drew
Hematology Oncology | Hematology | Oncology

Holy Cross Hospital Inc

4725 N Federal Hwy Nuclear Medicine, Holy Cross Medical Group, 
Ft Lauderdale, FL 
954-492-5748
Languages Spoken:
English, Mandarin
See accepted insurances
Accepting New Patients
Offers Telehealth

David Drew is a Hematologist Oncology specialist and a Hematologist in Ft Lauderdale, Florida. Dr. Drew is rated as an Advanced provider by MediFind in the treatment of Idiopathic Pulmonary Hemosiderosis. His top areas of expertise are Anemia, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, and Lung Cancer. Dr. Drew is currently accepting new patients.

View All Doctors
What are the latest Idiopathic Pulmonary Hemosiderosis Clinical Trials?
Leflunomide is Safe and Effective for the Induction and Maintenance of Idiopathic Pulmonary Hemosiderosis Remission
Leflunomide is Safe and Effective for the Induction and Maintenance of Idiopathic Pulmonary Hemosiderosis Remission
Enrollment Status: Recruiting
Publish Date: July 10, 2023
Intervention Type: Drug
Study Phase: Phase 1/Phase 2

Summary: The goal of this clinical trial is to compare Leflunomide in Idiopathic pulmonary hemosiderosis. The main questions it aims to answer are: * The efficacy and safety of Leflunomide in Idiopathic pulmonary hemosiderosis * The mechanism of leflunomide in treating Idiopathic pulmonary hemosiderosis Participants will be treated with leflunomide plus stroid. A comparison group: Researchers will compare ...

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center